0001181431-14-030477.txt : 20140828 0001181431-14-030477.hdr.sgml : 20140828 20140828195424 ACCESSION NUMBER: 0001181431-14-030477 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140826 FILED AS OF DATE: 20140828 DATE AS OF CHANGE: 20140828 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDIVATION, INC. CENTRAL INDEX KEY: 0001011835 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133863260 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 525 MARKET STREET STREET 2: 36TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 415-543-3470 MAIL ADDRESS: STREET 1: 525 MARKET STREET STREET 2: 36TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 FORMER COMPANY: FORMER CONFORMED NAME: ORION ACQUISITION CORP II DATE OF NAME CHANGE: 19960408 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Seely Lynn CENTRAL INDEX KEY: 0001327111 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32836 FILM NUMBER: 141073088 MAIL ADDRESS: STREET 1: 501 2ND STREET STREET 2: SUITE 211 CITY: SAN FRANCISCO STATE: CA ZIP: 94107 4 1 rrd415199.xml SEELY -- 8/26/14 EXERCISE AND SALE X0306 4 2014-08-26 0 0001011835 MEDIVATION, INC. MDVN 0001327111 Seely Lynn C/O MEDIVATION, INC. 525 MARKET ST., 36TH FLOOR SAN FRANCISCO CA 94105 0 1 0 0 Chief Medical Officer Common Stock 2014-08-26 4 M 0 5700 10.585 A 64722 D Common Stock 2014-08-26 4 S 0 5700 88.953 D 59022 D Common Stock 2014-08-27 4 M 0 14300 10.585 A 73322 D Common Stock 2014-08-27 4 S 0 11700 89.43 D 61622 D Common Stock 2014-08-27 4 S 0 2600 90.42 D 59022 D Stock Option (Right to Buy) 10.585 2014-08-26 4 M 0 5700 0.00 D 2017-10-01 Common Stock 5700 194300 D Stock Option (Right to Buy) 10.585 2014-08-27 4 M 0 14300 0.00 D 2017-10-01 Common Stock 14300 180000 D Shares sold pursuant to a 10b5-1 Plan. The shares were sold at prices ranging from $88.95 to $89.06. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Fully vested. The shares were sold at prices ranging from $89.00 to $89.97. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $90.01 to $90.95. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. /s/ Jennifer Rhodes, Attorney-in-fact 2014-08-27